Table 1 Demographics in 347 pulmonary embolism patients (193 women, 154 men), by gender and by hormone use

Hormone user, n = 24 (12 %)

Non user, n = 169 (88 %)

all women n = 193 (100 %)

 Age (year)

42 ± 13, median 38****

66 ± 17, median 69

63 ± 18, median 65

 Smoking

7/24 (29 %)*

96/169 (57 %)

103/193 (53 %)

 Hormone

BC pill 16 (67 %)

Estrogen 6 (25 %)

Progesterone 2 (8 %)

 Cancer

0/24 (0 %)**

45/169 (27 %)

45/193 (23 %)

 DM

2/24 (8 %)

42/169 (25 %)

44/193 (23 %)

 Death

0/24 (0 %)

3/169 (2 %)

3/193 (2 %)

 Thrombosis history

1/24 (4 %)*

40/168 (24 %), 1 missing

41/193 (21 %)

Hormone user, n = 8 (5 %)

Non user n = 146 (95 %)

All men n = 154 (100 %)

 Age (year)

48 ± 23, median 56

63 ± 17, median 65

62 ± 17, median 64

 Smoking

5/8 (63 %)

103/146 (71 %)

108/154 (70 %)

 Hormone

Testosterone

 Cancer

0/8 (0 %)

33/146 (23 %)

33/154 (21 %)

 DM

2/8 (25 %)

31/146 (21 %)

33/154 (21 %)

 Death

0/8 (0 %)

2/146 (1 %)

2/154 (1 %)

 Thrombosis history

2/8 (25 %)

31/146 (21 %)

33/154 (21 %)